Skip to main navigation Skip to search Skip to main content

Efficacy and Safety of Ombitasvir/Paritaprevir/Ritonavir/Dasabuvir plus /- Ribavirin Regimen for Recurrent Genotype 1 HCV Infection After Liver Transplantation - Multicenter, Real-Life, AMBER-CEE Study

  • Ieva Tolmane
  • , O. Tronina
  • , M. Durlik
  • , M. Wawrzynowicz-Syczewska
  • , A. Buivydiene
  • , Limas Kupčinskas
  • , K. Katzarov
  • , L. Kupcinskas
  • , E. Karpinska
  • , A. Pisula
  • , K. Karwowska

    Research output: Contribution to journalMeeting abstractpeer-review

    Original languageEnglish
    JournalTransplantation
    Volume100
    Publication statusPublished - 2016
    Event22nd Annual International Congress of the International Liver Transplantation Society - Seula, Korea, Republic of
    Duration: 4 May 20167 May 2016

    OECD Field of Science

    • 3. Medical and Health Sciences

    Cite this